183 related articles for article (PubMed ID: 18430116)
1. Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia.
Pastorekova S; Ratcliffe PJ; Pastorek J
BJU Int; 2008 Jun; 101 Suppl 4():8-15. PubMed ID: 18430116
[No Abstract] [Full Text] [Related]
2. Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma.
Pantuck AJ; Klatte T; Seligson D; Atkins M; Belldegrun A
J Clin Oncol; 2008 Jun; 26(18):3105-7; author reply 3107-9. PubMed ID: 18565906
[No Abstract] [Full Text] [Related]
3. Carbonic anhydrase IX: historical and future perspectives.
Oosterwijk E
BJU Int; 2008 Jun; 101 Suppl 4():2-7. PubMed ID: 18430115
[No Abstract] [Full Text] [Related]
4. Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.
Signoretti S; Regan M; Atkins M
BJU Int; 2008 Jun; 101 Suppl 4():31-5. PubMed ID: 18430120
[No Abstract] [Full Text] [Related]
5. Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma.
Jensen HK; Nordsmark M; Donskov F; Marcussen N; von der Maase H
BJU Int; 2008 Jun; 101 Suppl 4():41-4. PubMed ID: 18430123
[No Abstract] [Full Text] [Related]
6. Cancer-associated, hypoxia-inducible carbonic anhydrase IX facilitates CO2 diffusion.
Swietach P; Wigfield S; Supuran CT; Harris AL; Vaughan-Jones RD
BJU Int; 2008 Jun; 101 Suppl 4():22-4. PubMed ID: 18430118
[No Abstract] [Full Text] [Related]
7. Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies.
Shuch B; Li Z; Belldegrun AS
BJU Int; 2008 Jun; 101 Suppl 4():25-30. PubMed ID: 18430119
[No Abstract] [Full Text] [Related]
8. The use of positron-emission tomography in the diagnosis of tumour phenotype.
Divgi C
BJU Int; 2008 Jun; 101 Suppl 4():36-8. PubMed ID: 18430121
[No Abstract] [Full Text] [Related]
9. Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma.
Leppert JT; Lam JS; Pantuck AJ; Figlin RA; Belldegrun AS
BJU Int; 2005 Aug; 96(3):281-5. PubMed ID: 16042714
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy.
Brouwers AH; Mulders PF; Oyen WJ
J Clin Oncol; 2008 Aug; 26(22):3808-9; author reply 3811-2. PubMed ID: 18669472
[No Abstract] [Full Text] [Related]
11. Expression and diagnostic implications of carbonic anhydrase IX in several tumours with predominantly clear cell morphology.
Lin XY; Zhang H; Tang N; Zhang XP; Zhang W; Wang EH; Han YC
Histopathology; 2015 Apr; 66(5):685-94. PubMed ID: 25431204
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX expression in clear cell renal cell carcinomas negatively correlates with the proportion of the granular cell component.
Skapa P; Hyrsl L; Zavada J; Soukup J; Zamecnik J
J Clin Oncol; 2008 Aug; 26(22):3809-11; author reply 3811-2. PubMed ID: 18669473
[No Abstract] [Full Text] [Related]
13. In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer.
Brouwers AH; Boerman OC; Oyen WJ
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8886; author reply 8886. PubMed ID: 16361579
[No Abstract] [Full Text] [Related]
14. [Comment to "Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression"].
Salinas AS
Actas Urol Esp; 2011 Feb; 35(2):87-8. PubMed ID: 21288602
[No Abstract] [Full Text] [Related]
15. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
[TBL] [Abstract][Full Text] [Related]
16. Kidney cancer: Carbonic anhydrase IX in resected clear cell RCC.
Pickering LM; Larkin J
Nat Rev Urol; 2015 Jun; 12(6):309-10. PubMed ID: 26032554
[No Abstract] [Full Text] [Related]
17. Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.
Genega EM; Ghebremichael M; Najarian R; Fu Y; Wang Y; Argani P; Grisanzio C; Signoretti S
Am J Clin Pathol; 2010 Dec; 134(6):873-9. PubMed ID: 21088149
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis.
Giménez-Bachs JM; Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SH; Rubio-Del Campo A; Sánchez-Prieto R
Scand J Urol Nephrol; 2012 Oct; 46(5):358-64. PubMed ID: 22571179
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target.
Potter C; Harris AL
Cell Cycle; 2004 Feb; 3(2):164-7. PubMed ID: 14712082
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED
J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
